A fascinating study published in 2018 found patients suffering from cancer-related fatigue displayed significant improvement ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

One analysis of antidepressants approved by the Food and Drug Administration (fda) in America found that, among the 51 ...

In this post, I explain how a newly introduced bias—likelihood neglect bias—can prevent us from forming accurate judgments ...

AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...

Social media is enabling health symptoms and mass psychogenic illnesses to spread quickly around the world. But by knowing how it happens, you can protect yourself ...

Gregg Stone cast doubt on its reliability in trials, while David Cohen said QoL matters to patients and should be measured.

When we put a call out to readers this month to send us their questions and concerns about sleep and aging, one of the most ...

This present study was a randomised, two-way, crossover, double-blind, placebo-controlled clinical trial that aimed to evaluate the psychomotor effects of mexazolam when administered in a single ...

AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing a first-in-class therapeutic for peripheral ...

A new study, led by Professor Jan Inge Henter and published in the New England Journal of Medicine, examined whether the drug ...